Aralez revenues up 47% in Q1

|About: Aralez Pharmaceuticals Inc. (ARLZ-OLD)|By:, SA News Editor

Aralez Pharmaceuticals (ARLZ) Q1 results: Revenues: $38.1M (+46.5%); Product revenues: $34M; Other revenues: $4.1M (-78.8%).

Net Loss: ($19.7M) (+28.4%); Loss Per Share: ($0.29) (+31.0%); Quick Assets: $43.9M (+51.9%).

Shares are down 24% premarket.

Subscribe for full text news in your inbox